Scholarlink

<p>This trial aimed to explore the effect of supervised breathing exercises (BEs) on depression, sexual function, and exercise capacity in postmenopausal women. Sixty-four depressed postmenopausal women with associated sexual dysfunction were equally assigned to either a BEs group, which received diaphragmatic BEs, or a non-exercising control group. Both groups received individualized antidepressants and vaginal lubricants. Depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II), sexual function using the Female Sexual Function Index (FSFI), and exercise capacity using the six-minute walk test (6MWT) at baseline and after 12 weeks. At the end of the study, the BEs group showed significantly greater reductions in BDI-II scores (mean difference = − 4.22; 95% CI, − 6.19 to − 2.24; <i>p</i> = 0.001) and significantly greater increases in FSFI scores (mean difference = 5.01; 95% CI, 3.21 to 6.79; <i>p</i> = 0.001) compared with the control group with clinically significant differences for both measures. However, the between-group difference in 6MWT distance was not significant (mean difference = 28.28&#xa0;m; 95% CI, − 2 to 58.57; <i>p</i> = 0.06). BEs could be an effective therapeutic intervention for managing depression and sexual dysfunction in this population of postmenopausal women, while no significant effect was observed on exercise capacity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effect of breathing exercises on depression, sexual function, and exercise capacity in postmenopausal women: a randomized controlled trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月23日

查看全文
  • Saher Lotfy Elgayar

摘要

This trial aimed to explore the effect of supervised breathing exercises (BEs) on depression, sexual function, and exercise capacity in postmenopausal women. Sixty-four depressed postmenopausal women with associated sexual dysfunction were equally assigned to either a BEs group, which received diaphragmatic BEs, or a non-exercising control group. Both groups received individualized antidepressants and vaginal lubricants. Depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II), sexual function using the Female Sexual Function Index (FSFI), and exercise capacity using the six-minute walk test (6MWT) at baseline and after 12 weeks. At the end of the study, the BEs group showed significantly greater reductions in BDI-II scores (mean difference = − 4.22; 95% CI, − 6.19 to − 2.24; p = 0.001) and significantly greater increases in FSFI scores (mean difference = 5.01; 95% CI, 3.21 to 6.79; p = 0.001) compared with the control group with clinically significant differences for both measures. However, the between-group difference in 6MWT distance was not significant (mean difference = 28.28 m; 95% CI, − 2 to 58.57; p = 0.06). BEs could be an effective therapeutic intervention for managing depression and sexual dysfunction in this population of postmenopausal women, while no significant effect was observed on exercise capacity.